Jun Miyazaki

Trained immunity: A program of innate immune memory in health and disease

The gut microbiota and host health: a new clinical frontier

Cutting Edge: Tlr5 −/− Mice Are More Susceptible to Escherichia coli Urinary Tract Infection

Cancer treatment and survivorship statistics, 2022

An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study

Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review

Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates

Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?

Innate immune memory in mammals

Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity

Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer

The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review

Bladder cancer

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

Uncomplicated Urinary Tract Infection

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

<p>Antimicrobial Resistance: Implications and Costs</p>

Immunological memory cells

Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial

Urinary tract infections: epidemiology, mechanisms of infection and treatment options

Defining trained immunity and its role in health and disease

Uropathogenic Escherichia coli Releases Extracellular Vesicles That Are Associated with RNA

An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases

Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses

Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer

Bladder Cancer

Cancer treatment and survivorship statistics, 2016

Cancer treatment and survivorship statistics, 2019

Waging War against UropathogenicEscherichia coli: Winning Back the Urinary Tract

Cancer treatment and survivorship statistics, 2014

Risk Factors for Intravesical Recurrence in Patients with High-grade T1 Bladder Cancer in the Second TUR Era

Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi‐institutional nationwide case series study of the Japanese Urological Association

Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer

Identification of a type III secretion system in uropathogenicEscherichia coli

Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenicEscherichia colito adhere to and invade bladder epithelial cells

Antibacterial Activity and Clinical Efficacy of Sparfloxacin in Mycobacterium avium-intracellulare Complex Infection

Bacillus Calmette–Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine